Xenetic Biosciences (XBIO) Competitors $3.19 -0.08 (-2.45%) Closing price 03:35 PM EasternExtended Trading$3.20 +0.01 (+0.19%) As of 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIO vs. NAII, ALVR, PRPH, EDSA, IBIO, LSB, BLRX, THAR, CLRB, and FLGCShould you be buying Xenetic Biosciences stock or one of its competitors? The main competitors of Xenetic Biosciences include Natural Alternatives International (NAII), AlloVir (ALVR), ProPhase Labs (PRPH), Edesa Biotech (EDSA), iBio (IBIO), LakeShore Biopharma (LSB), BioLineRx (BLRX), Tharimmune (THAR), Cellectar Biosciences (CLRB), and Flora Growth (FLGC). These companies are all part of the "pharmaceutical products" industry. Xenetic Biosciences vs. Its Competitors Natural Alternatives International AlloVir ProPhase Labs Edesa Biotech iBio LakeShore Biopharma BioLineRx Tharimmune Cellectar Biosciences Flora Growth Natural Alternatives International (NASDAQ:NAII) and Xenetic Biosciences (NASDAQ:XBIO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Does the media favor NAII or XBIO? In the previous week, Natural Alternatives International's average media sentiment score of 1.00 beat Xenetic Biosciences' score of 0.00 indicating that Natural Alternatives International is being referred to more favorably in the media. Company Overall Sentiment Natural Alternatives International Positive Xenetic Biosciences Neutral Do insiders & institutionals believe in NAII or XBIO? 32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 15.1% of Xenetic Biosciences shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by insiders. Comparatively, 14.7% of Xenetic Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable earnings and valuation, NAII or XBIO? Xenetic Biosciences has lower revenue, but higher earnings than Natural Alternatives International. Natural Alternatives International is trading at a lower price-to-earnings ratio than Xenetic Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$113.80M0.18-$7.22M-$1.39-2.34Xenetic Biosciences$2.45M2.01-$3.96M-$2.00-1.60 Which has more risk and volatility, NAII or XBIO? Natural Alternatives International has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Comparatively, Xenetic Biosciences has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500. Do analysts rate NAII or XBIO? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Xenetic Biosciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is NAII or XBIO more profitable? Natural Alternatives International has a net margin of -6.56% compared to Xenetic Biosciences' net margin of -126.08%. Natural Alternatives International's return on equity of -10.34% beat Xenetic Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.56% -10.34% -5.19% Xenetic Biosciences -126.08%-54.56%-47.28% SummaryNatural Alternatives International beats Xenetic Biosciences on 8 of the 13 factors compared between the two stocks. Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIO vs. The Competition Export to ExcelMetricXenetic BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.04M$2.55B$5.76B$10.29BDividend YieldN/A57.28%5.74%4.60%P/E Ratio-1.6023.4276.8626.96Price / Sales2.01717.16539.94127.44Price / CashN/A169.7137.1760.63Price / Book0.825.4313.836.37Net Income-$3.96M$32.95M$3.29B$271.46M7 Day Performance3.20%0.84%0.93%2.35%1 Month Performance9.70%6.04%5.31%7.78%1 Year Performance-12.60%-0.89%84.25%32.27% Xenetic Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBIOXenetic Biosciences0.5911 of 5 stars$3.19-2.4%N/A-11.6%$5.04M$2.45M-1.604Gap UpNAIINatural Alternatives International1.4144 of 5 stars$3.13-3.1%N/A-53.1%$19.34M$113.80M-2.25290Positive NewsALVRAlloVirN/A$3.71-4.6%N/A-71.0%$18.71MN/A-0.18110High Trading VolumePRPHProPhase Labs1.1936 of 5 stars$0.43+1.0%N/A-83.9%$18.04M$6.77M-0.34130EDSAEdesa Biotech1.2813 of 5 stars$2.46+2.5%$5.00+103.3%-44.0%$17.31MN/A-1.8620IBIOiBio1.6914 of 5 stars$0.86-3.4%$5.00+478.5%-55.4%$16.99M$400K-0.50100LSBLakeShore Biopharma1.2295 of 5 stars$0.81+0.1%N/A-89.9%$16.73M$614.96M0.00773Short Interest ↓Gap DownBLRXBioLineRx2.6898 of 5 stars$3.89+3.7%$26.00+568.4%-84.8%$16.57M$28.94M-0.4440THARTharimmune2.3067 of 5 stars$2.88-2.0%$17.00+490.3%-10.4%$16.39MN/A-0.472Gap UpCLRBCellectar Biosciences3.3918 of 5 stars$5.13-0.4%$375.00+7,209.9%-92.0%$16.37MN/A-0.2610Short Interest ↓FLGCFlora Growth3.0628 of 5 stars$28.07+10.5%$93.00+231.4%-34.1%$16.28M$59.51M-0.82280News CoverageShort Interest ↓Gap DownHigh Trading Volume Related Companies and Tools Related Companies NAII Competitors ALVR Competitors PRPH Competitors EDSA Competitors IBIO Competitors LSB Competitors BLRX Competitors THAR Competitors CLRB Competitors FLGC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIO) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredOctober 28–29: The Sequel to Powell’s 0.25% Rate ShockThe Fed just cut rates — and Wall Street insiders are already repositioning. While Powell’s 0.25% move may loo...American Alternative | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
